The September 2016 edition of the Pistoia Alliance newsletter, Innovation in Action, is available to download as a PDF document.
The Pistoia Alliance are delighted to announce an exciting additional award for the 2016 President’s Challenge from Thomson Reuters.
The Pistoia Alliance, an organization dedicated to improving global life sciences R&D, has seen its membership increase with a number of new members including both large multinationals and start-ups.
Contest will see startup companies compete to develop new ways to improve innovation in life sciences R&D.
Lowering Barriers to R&D Innovation
We are a global, not-for-profit alliance of life science companies, vendors, publishers, and academic groups that work together to lower barriers to innovation in R&D.
Our projects transform R&D innovation through pre-competitive collaboration. We bring together the key constituents to identify the root causes that lead to R&D inefficiencies. We develop best practices and technology pilots to overcome common obstacles.
Our members collaborate as equals on open projects that generate significant value for the worldwide life sciences community.
With the launch of our Interactive Project Portfolio Platform (IP3) we are embracing a new level of openness, access, and transparency around our idea-to-project process. The platform is open to the public to submit new ideas, comment and vote on proposed ideas, and monitor the progress of our projects.
Since August 2016 the Pistoia Alliance has welcomed several companies and individuals as new members.
The Pistoia Alliance Advisory Board met on Wednesday 29th March. Steve Arlington, President of the Pistoia Alliance, invited its members to consider the biopharma and healthcare landscape as it might be in 2030.